| |
Total
|
DIA without HYP
|
DIA with HYP
|
HYP without DIA
|
|---|
|
Antihypertensive drugs (%)
|
47.21
| |
100.00
|
58.19
|
|
Diuretics (%)
|
41.67
| |
50.00
|
43.26
|
|
ACEi (%)
|
39.58
| |
43.75
|
33.65
|
|
ARB (%)
|
34.03
| |
40.00
|
35.58
|
|
β-blockers (%)
|
29.86
| |
31.25
|
32.69
|
|
α-blockers (%)
|
5.56
| |
7.50
|
2.88
|
|
Calcium antagonists (%)
|
18.06
| |
23.75
|
18.27
|
|
Other antihypertensive drugs (%)
|
1.39
| |
0.00
|
1.92
|
|
Antidiabetic drugs (%)
|
21.987
|
84.38
|
87.50
| |
|
Insulin (%)
|
20.90
|
29.63
|
20.00
| |
|
Metformin (%)
|
83.58
|
85.19
|
80.00
| |
|
Sulfonylureas (%)
|
32.84
|
14.81
|
37.14
| |
|
Meglitinides (%)
|
2.99
|
7.41
|
4.29
| |
|
α-glucosidase inhibitors (%)
|
1.49
| |
1.43
| |
|
Glitazones (%)
| | |
7.14
| |
- Data are expressed as percentages. ACEi, angiotensin-converting enzyme inhibitors; ARB, angiotensin receptor blockers; DIA, patients with diabetes; HYP, patients with hypertension.
